deoxycytidine has been researched along with Respiratory Syncytial Virus Infections in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Behera, I; Decroly, E; Eléouët, JF; Fung, A; Gilman, MSA; Jin, Z; Jordan, P; Liu, C; McLellan, JS; Rigaux, P; Roymans, D; Sourimant, J; Sutto-Ortiz, P; Tcherniuk, S; Ysebaert, N | 1 |
| Beigelman, L; Blatt, LM; Chanda, S; DeVincenzo, JP; Fry, J; Huntjens, DR; Kirkpatrick, CM; McClure, M; Nieforth, KA; Patel, K; Smith, PF; Symons, JA; Zhang, Q | 1 |
| Beigelman, L; Blatt, LM; Chanda, SM; Deval, J; Dyatkina, N; Fung, A; Hong, J; Jin, Z; Liu, J; Prhavc, M; Serebryany, V; Smith, DB; Stevens, SK; Symons, JA; Tam, Y; Taylor, J; Wang, G; Zhang, Q | 1 |
| Beigelman, L; Blatt, LM; Chanda, S; DeVincenzo, JP; Fathi, H; Fry, J; Lambkin-Williams, R; McClure, MW; Smith, P; Symons, JA; Westland, C; Zhang, Q | 1 |
| DeVincenzo, JP; Fry, J; McClure, MW | 1 |
| Arasaratnam, R | 1 |
| Deval, J; Fearns, R | 1 |
| Beigelman, L; Chaudhuri, S; Deval, J; Dyatkina, N; Jordan, PC; Pemberton, RP; Stevens, SK; Stoycheva, AD; Symons, JA; Tam, Y; Wang, G | 1 |
1 review(s) available for deoxycytidine and Respiratory Syncytial Virus Infections
| Article | Year |
|---|---|
New antiviral approaches for respiratory syncytial virus and other mononegaviruses: Inhibiting the RNA polymerase.
Topics: Antiviral Agents; Clinical Trials as Topic; Deoxycytidine; DNA-Directed RNA Polymerases; Hemorrhagic Fever, Ebola; Humans; Measles; Mononegavirales; Nucleosides; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; RNA-Dependent RNA Polymerase; RNA, Messenger; Transcription, Genetic; Virus Replication | 2016 |
2 trial(s) available for deoxycytidine and Respiratory Syncytial Virus Infections
| Article | Year |
|---|---|
Respiratory syncytial virus-A dynamics and the effects of lumicitabine, a nucleoside viral replication inhibitor, in experimentally infected humans.
Topics: Adult; Antiviral Agents; Deoxycytidine; Double-Blind Method; Healthy Volunteers; Humans; Models, Theoretical; Nasopharynx; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Viral Load; Virus Replication | 2019 |
Activity of Oral ALS-008176 in a Respiratory Syncytial Virus Challenge Study.
Topics: Administration, Oral; Adolescent; Adult; Antiviral Agents; Area Under Curve; Deoxycytidine; Double-Blind Method; Female; Humans; Male; Middle Aged; Mucus; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Viral Load; Virus Replication; Young Adult | 2015 |
5 other study(ies) available for deoxycytidine and Respiratory Syncytial Virus Infections
| Article | Year |
|---|---|
Structure of the Respiratory Syncytial Virus Polymerase Complex.
Topics: Acetates; Animals; Antiviral Agents; Catalytic Domain; Cryoelectron Microscopy; Deoxycytidine; Hydrogen Bonding; Hydrophobic and Hydrophilic Interactions; Phosphoproteins; Protein Conformation, alpha-Helical; Protein Interaction Domains and Motifs; Quinolines; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus Vaccines; Respiratory Syncytial Virus, Human; RNA-Dependent RNA Polymerase; Sf9 Cells; Spodoptera; Viral Proteins; Virus Replication | 2019 |
Discovery of 4'-chloromethyl-2'-deoxy-3',5'-di-O-isobutyryl-2'-fluorocytidine (ALS-8176), a first-in-class RSV polymerase inhibitor for treatment of human respiratory syncytial virus infection.
Topics: Animals; Antiviral Agents; Cricetinae; Deoxycytidine; DNA-Directed DNA Polymerase; DNA-Directed RNA Polymerases; Dose-Response Relationship, Drug; Drug Discovery; Enzyme Inhibitors; Haplorhini; Humans; Male; Molecular Conformation; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Prodrugs; Rats; Rats, Sprague-Dawley; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Structure-Activity Relationship; Virus Replication | 2015 |
ALS-008176 for Respiratory Syncytial Virus Infection.
Topics: Antiviral Agents; Deoxycytidine; Female; Humans; Male; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses | 2016 |
ALS-008176 for Respiratory Syncytial Virus Infection.
Topics: Antiviral Agents; Deoxycytidine; Female; Humans; Male; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses | 2016 |
Activation Pathway of a Nucleoside Analog Inhibiting Respiratory Syncytial Virus Polymerase.
Topics: Activation, Metabolic; Antiviral Agents; Deoxycytidine; Deoxycytidine Kinase; Drug Discovery; Humans; Phosphorylation; Prodrugs; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Virus Replication | 2017 |